UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | Life Sciences & Biomedicine | Oncology | Science & Technology | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 26, pp. 2518 - 2528
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Enzyme Inhibitors - adverse effects | Lung Diseases, Interstitial - etiology | Double-Blind Method | Administration, Oral | Humans | Middle Aged | Male | Diarrhea - chemically induced | Enzyme Inhibitors - therapeutic use | Lung Diseases, Interstitial - drug therapy | Disease Progression | Vital Capacity | Indoles - adverse effects | Scleroderma, Systemic - complications | Adult | Female | Indoles - therapeutic use | Lung Diseases, Interstitial - physiopathology | Scleroderma, Systemic - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Drug therapy | Sclerosis | Tyrosine | Mycophenolic acid | Sensitivity analysis | Lung diseases | Rheumatology | Oral administration | Clinical trials | Diarrhea | Patients | Pulmonary hypertension | Pulmonary fibrosis | Computed tomography | Systemic sclerosis | Technical communication | Fibrosis | Skin | Scleroderma | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 18, pp. 1718 - 1727
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Disease Progression | Vital Capacity - drug effects | Indoles - adverse effects | Protein Kinase Inhibitors - therapeutic use | Female | Indoles - therapeutic use | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Drug therapy | Lung diseases, Interstitial | Patient outcomes | Tyrosine | Genotype & phenotype | Computed tomography | Technical communication | Lung diseases | Questionnaires | Fibrosis | Diarrhea | Carbon monoxide | Patients | Population decline | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article